Federated Hermes’s CalciMedica CALC Stock Holding History

Federated Hermes’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-170	Closed	-$1.19K	–	2136
2022 Q4	$1.19K	Hold	170	–	–	﹤0.01%	2046
2022 Q3	$2K	Hold	170	–	–	﹤0.01%	1963
2022 Q2	$3K	Buy	170 +20	+13%	+$273	﹤0.01%	1938
2022 Q1	$3K	Buy	150 +92	+159%	+$1.75K	﹤0.01%	1992
2021 Q4	$1K	Buy	+58	New	+$2.25K	﹤0.01%	2094

Federated Hermes's CALC Position: Q1 2023 in Review

Federated Hermes sold out of CalciMedica (CALC) in Q1 2023, closing a stake of 170 shares — an estimated $1.19K sold.

Federated Hermes first reported a position in CALC in Q4 2021 and held it in 5 quarters. The position peaked at $3K in Q2 2022. 0 funds tracked by Wall St. Rank hold CALC as of Q1 2023.

Federated Hermes reported no remaining CalciMedica position as of Q1 2023 after selling out during the quarter.
Federated Hermes sold 170 CalciMedica shares in Q1 2023, an estimated $1.19K.
Federated Hermes first reported a position in CalciMedica in Q4 2021 and held it in 5 quarters.
Federated Hermes's CalciMedica position peaked at $3K in Q2 2022.
0 funds tracked by Wall St. Rank held CalciMedica as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.